Graf Akcie AZN (Astrazeneca plc). Diskuze k akciím AZN. Aktuální informace AZN.

Základní informace o společnosti Astrazeneca plc (Akcie AZN)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 159.24B
Hodnota podniku (EV) 186.13B
Tržby 29.528B
EBITDA 6.638B
Zisk 3.768B
Růst v tržbách Q/Q 31.00 %
Růst v tržbách Y/Y 14.90 %
P/E (Cena vůči ziskům) 41.82
Forward P/E 16.78
EV/Sales 6.30
EV/EBITDA 28.04
EV/EBIT 32.85
PEG 1.02
Price/Sales 5.39
P/FCF 29.54
Price/Book 10.19
Účetní hodnota na akcii 5.91
Hotovost na akcii 3.02
FCF vůči ceně 3.38 %
Počet zaměstnanců 76,100
Tržba na zaměstnance 388.016k
Profit margin 11.81 %
Operating margin 19.24 %
Gross margin 80.09 %
EBIT margin 19.19 %
EBITDA margin 22.48 %
EPS - Zisk na akcii 1.44
EPS - Kvartální růst -6.25 %
EPS - Očekávaný růst příští rok 40.43 %
Return on assets 5.59 %
Return on equity 26.02 %
ROIC 8.25 %
ROCE 11.02 %
Dluhy/Equity 3.27
Čistý dluh/EBITDA 7.61
Current ratio 1.23
Quick Ratio 1.01
Volatilita 1.64
Beta 0.19
RSI 59.12
Cílová cena analytiků 69
Známka akcie (dle analytiků) 1.60
Insider ownership 0.01 %
Institutional ownership 15.78 %
Počet akcií 2.626B
Procento shortovaných akcií N/A %
Short ratio 0.33 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 1993
Země United Kingdom

Finanční výsledky akcie AZN

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$26,617$24,384$22,090$22,465$23,002$24,708
Cost Of Goods Sold$5,299$4,921$4,936$4,318$4,126$4,646
Gross Profit$21,318$19,463$17,154$18,147$18,876$20,062
Research And Development Expenses$5,991$6,059$5,932$5,757$5,890$5,997
SG&A Expenses$11,693$12,021$10,362$10,543$9,739$11,451
Other Operating Income Or Expenses$1,528$1,541$2,527$1,830$1,655$1,500
Operating Expenses$21,455$21,460$18,703$18,788$18,100$20,594
Operating Income$5,162$2,924$3,387$3,677$4,902$4,114
Total Non-Operating Income/Expense$-1,246$-1,376$-1,394$-1,450$-1,350$-1,045
Pre-Tax Income$3,916$1,548$1,993$2,227$3,552$3,069
Income Taxes$772$321$-57$-641$146$243
Income After Taxes$3,144$1,227$2,050$2,868$3,406$2,826
Other Income------
Income From Continuous Operations$3,144$1,227$2,050$2,868$3,406$2,826
Income From Discontinued Operations------
Net Income$3,196$1,335$2,155$3,001$3,499$2,825
EBITDA$8,311$6,686$7,140$6,713$7,259$6,966
EBIT$5,162$2,924$3,387$3,677$4,902$4,114
Basic Shares Outstanding2,6242,6022,5342,5322,5302,528
Shares Outstanding2,6262,6022,5342,5322,5322,530
Basic EPS$1.22$0.52$0.85$1.19$1.39$1.11
EPS - Earnings Per Share$1.22$0.52$0.85$1.19$1.38$1.11
# 2020 2019 2018 2017 2016 2015
Current Ratio0.96240.8590.9570.80270.86931.0765
Long-term Debt / Capital0.52820.51870.55280.48320.46520.433
Debt/Equity Ratio1.25971.20251.36091.071.00830.8133
Gross Margin80.091779.818777.65580.77982.062481.1964
Operating Margin19.393611.991515.332716.367721.311216.6505
EBIT Margin19.393611.991515.332716.367721.311216.6505
EBITDA Margin31.224427.419632.322329.88231.558128.1933
Pre-Tax Profit Margin14.71246.34849.02229.913215.442112.4211
Net Profit Margin12.00745.47499.755513.358615.211711.4335
Asset Turnover0.39890.39730.36420.35460.36790.4114
Inventory Turnover Ratio1.31681.54121.7081.42271.76782.168
Receiveable Turnover3.60374.03313.82114.06024.60133.5252
Days Sales In Receivables101.284590.501695.521389.897479.3251103.5408
ROE - Return On Equity20.10498.406414.59717.233520.433115.2683
Return On Tangible Equity-18.3281-6.8528-10.4475-13.4201-15.0875-17.7323
ROA - Return On Assets4.71161.99913.384.52695.44734.7056
ROI - Return On Investment9.48624.0466.5288.906310.92728.6565
Book Value Per Share5.95665.56195.54216.57156.58737.3209
Operating Cash Flow Per Share0.68650.1079-0.38-0.22390.3232-1.4781
Free Cash Flow Per Share0.72290.1527-0.2959-0.17610.2908-1.6466